Venous thrombosis: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz m (Superficial venous thrombosis moved to Venous thrombosis: Clean up uncategorized article by moving the general/stubby to a more general title) |
(No difference)
| |
Revision as of 13:33, 14 October 2010
Venous thrombosis is one of several diseases caused by inappropriate blood clots (thrombi) in veins principally of the arms and legs. The major area of concern is deep venous thrombosis, although there is also superficial venous thrombosis.
Deep venous thrombosis
Superficial venous thrombousis
Prognosis
Superficial venous thrombosis can be associated with deep venous thrombosis and an accompanying deep venous thrombosis occurring simultaneously or later.[1]
Treatment
"Fondaparinux at a dose of 2.5 mg once a day for 45 days was effective in the treatment of patients with acute, symptomatic superficial-vein thrombosis of the legs and did not have serious side effects" according to a randomized controlled trial. [2]
References
- ↑ Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M et al. (2010). "Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study.". Ann Intern Med 152 (4): 218-24. DOI:10.1059/0003-4819-152-4-201002160-00006. PMID 20157136. Research Blogging.
- ↑ Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B et al. (2010). "Fondaparinux for the treatment of superficial-vein thrombosis in the legs.". N Engl J Med 363 (13): 1222-32. DOI:10.1056/NEJMoa0912072. PMID 20860504. Research Blogging.